About the Drug Control Authority (DCA)

User Rating: 0 / 5

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

OBJECTIVES

The Drug Control Authority (DCA) is the executive body established under the Control of Drugs and Cosmetics Regulations 1984.The main task of this Authority is to ensure the safety, quality and efficacy of pharmaceuticals, health and personal care products that are marketed in Malaysia.

This objective is being achieved through the following:

  • Registration of pharmaceutical products and cosmetics
  • Licensing of premises for importer, manufacturer and wholesaler
  • Monitoring the quality of registered products in the market
  • Adverse Drug Reaction Monitoring

 

IMPLEMENTATION

The Control of Drugs and Cosmetics Regulations 1984 empowers the DCA to implement the registration scheme in phases i.e.

Phase 1
Pharmaceutical products which contain scheduled poisons as defined in the Poisons Act 1952 (1st November 1985)
Phase 2
Pharmaceutical products that do not contain scheduled poisons, other than traditional medicines (1st August 1988)
Phase 3
Traditional medicines (1st January 1992)
Phase 4
Cosmetics
  • hair dyes containing phenylenediamine, toluenediamine, salt and derivatives (1 st August,1991)
  • tooth whiteners containing hydrogen peroxide / carbamide peroxide (1st February,1996)
  • all cosmetic products other than listed above (1st February 2002)
Phase 5
Registration - Veterinary (Aug 2007)
Phase 6
Registration beginning with NCE (Jan 2012)

Notes ** Cosmetics registration was replaced by the Notification Procedure as of 1 Januari 2008

The DCA also ensures that all registered / notified products are labelled according to stipulated labeling requirements

 

TERMS OF REFERENCE

DCA Terms of Reference

 

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Newsletter Subsription

Site Last Modified

  • Last Modified: Friday 14 December 2018, 08:46:08.
© Copyright 2018 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA